Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s CAPItello-292 study aims to evaluate the ...

Lantern Pharma advances pediatric CNS cancer treatment with FDA guidance on LP-184 trial, targeting rare tumors and enhancing ...

EMERYVILLE, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...

Shares of Serina Therapeutics gained after the company said the Food and Drug Administration supports its trial design for an advanced Parkinson's treatment. The stock rose 28%, to $7.24, in ...

Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful to have participated in clinical trials that changed the trajectory of her ...

bDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada ...